Hepatoprotective Effect of Lactic Acid Bacteria, Inhibitors of $\beta$-Glucuronidase Production Against Intestinal Microflora

  • Published : 2005.03.01


The hepatoprotective activity of lactic acid bacteria (Lactobacillus brevis HY7401, Lactobacillus acidophilus CSG and Bifidobacterium longum HY8001), which inhibited $\beta$-glucuronidase productivity of intestinal microflora, on t-BHP- or CCl$_4$-induced hepatotoxicity of mice were evaluated. These oral administration of lactic acid bacteria lowered $\beta$-glucuronidase production of intestinal microflora as well as Escherichia coli HGU-3. When lactic acid bacteria at a dose of 0.5 or 2 g (wet weight)/kg was orally administered on CCl$_4$-induced liver injury in mice, these bacteria significantly inhibited the increase of plasma alanine transferase and aspartate transferase activities by $17-57\%$ and $57-66\%$ of the $CCI_4$ control group, respectively. These lactic acid bacteria also showed the potent hepatoprotective effect against t-BHP-induced liver injury in mice. The inhibitory effects of these lactic acid bacteria were more potent than that of dimethyl diphenyl bicarboxylate (DDB), which have been used as a commercial hepatoprotective agent. Among these lactic acid bacteria, L. acidophilus CSG exhibited the most potent hepatoprotective effect. Based on these findings, we insist that an inhibitor of $\beta$-glucuronidase production in intestine, such as lactic acid bacteria, may be hepatoprotective.



  1. Dutton, G. J., Glucuronidation of drugs and other compounds. CRC press, Florida pp. 1-42 (1980)
  2. Goldin, B. and Gorbach, S. L., The relationship between diet and rat fecal bacterial enzymes implicated in colon cancer. J. Natl. Cancer Ints., 57, 371-375 (1976) https://doi.org/10.1093/jnci/57.2.371
  3. Hill, M. J. and Crowther, J. S., Hill, M. J. and Crowther, J. S., . Cancer Res., 35, 3407-3417 (1975)
  4. Kinoshita, N. and Gelvoin, H,V., $\beta$-Glucuronidase catalyzed hydrolysis of benzo[a]pyrene-3-glucuronide and binding to DNA. Science, 199, 307-309 (1978) https://doi.org/10.1126/science.619459
  5. Kim, D.-H., Kang, H.-J., Park, S.-H., and Kobashi, K., Characterization of $\beta$-glucuronidase and $\beta$-glucosidase of alkalotolerant intestinal bacteria. Biol. Pharm. Bull., 17, 423- 425 (1994) https://doi.org/10.1248/bpb.17.423
  6. Kim, D.-H., Lee, J. H., Bae, E. A., and Han, M. J., Induction and inhibition of indole production of intestinal bacterial. Arch. Pharm. Res., 18, 351-355 (1995a) https://doi.org/10.1007/BF02976331
  7. Kim, D.-H., Jang, I. S., Park, J. B., and Lee, S. W., Protective role of mushrooms in experimental colon carcinogenesis. Arch. Pharm. Res., 18, 79-83 (1995b) https://doi.org/10.1007/BF02979138
  8. Kim, D.-H., Jin, Y. H., Jung, E. A., Han, M. J., and Kobashi, K., Purification and characterization of $\beta$-glucuronidase from E. coli HGU-3, a human intestinal bacterium. Biol. Pharm. Bull., 18, 1184-1188 (1995c) https://doi.org/10.1248/bpb.18.1184
  9. Levy, G. A., Kerr, L. M. H., and Campbell, J. C., $\beta$-Glucuronidase and cell proliferation. Biochem. J., 42, 462-468 (1948) https://doi.org/10.1042/bj0420462
  10. Mills, G. T. and Smith, E. E. B., The $\beta$-glucuronidase activity of chemically induced rat hepatoma. Science, 114, 690-692 (1951) https://doi.org/10.1126/science.114.2974.690
  11. Mills, G. T., Paul, J., and Smith, E. E. B., Studies in $\beta$-glucuronidase, the influence of age, partial hepatectomy and other factors in the $\beta$-glucuronidase activity in rate liver. Biochem. J., 53, 232-245 (1953) https://doi.org/10.1042/bj0530232
  12. Kim, D.-H., Jin, Y.-H., Park, J.-B., and Kobashi, K., Silymarin and its components are inhibitors of $\beta$-glucuronidase. Biol. Pharm. Bull., 17, 443-445 (1994) https://doi.org/10.1248/bpb.17.443
  13. Shim, S. B., Kim, N. J., and Kim, D.-H., $\beta$-Glucuronidase inhibitory activity and hepatoprotective effect of 18$\beta$-glycrrhetinic acid from the rhizomes of Glycyrrhiza uralensis. Plant Med., 66, 40-43 (2000) https://doi.org/10.1055/s-2000-11109
  14. Stahl, P. D., and Fishman, W. H., $\beta$-Glucuronidase In Bergmeyer, H. U. (ed). Method of Enzymatic Analysis. Verlag Chemie GmbH, Weinheim. 4, pp 246-256 (1983)
  15. Pineda, E. P., Goldberg, J. A., Banks, B. M., and Rutenburg, A. M., The significance of serum $\beta$-glucuronidase activity in patients with liver disease. Gastroenterology, 36, 202-213 (1959)
  16. Reitman, S. and Frankel, S., A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase. Am. J. Clin. Path., 28, 56-63 (1957) https://doi.org/10.1093/ajcp/28.1.56
  17. Wang, W. L., Clinical effect of DDB piles on 56 cases of chronic viral hepatitis B. New Drugs Clinic, 3, 13-15 (1984)
  18. Weiburger, J. H., Reddy, B. S., and Wynder, E. L., Colon cancer: its epidemiology and experimental production. Cancer, 40, 2414-2420 (1977) https://doi.org/10.1002/1097-0142(197711)40:5+<2414::AID-CNCR2820400904>3.0.CO;2-D